In vivo multimodality imaging of miRNA-16 iron nanoparticle reversing drug resistance to chemotherapy in a mouse gastric cancer model

Nanoscale

Volumn 6, Issue 23, 2014, Pages 14343-14353

  Sun, Zhongchan ^a,b   Song, Xinxing ^b,c   Li, Xiujuan ^b   Su, Tao ^b   Qi, Shun ^b   Qiao, Ruirui ^d   Wang, Fu ^e   Huan, Yi ^b   Yang, Weidong ^b   Wang, Jing ^b   Nie, Yongzhan ^b   Wu, Kaichun ^b   Gao, Mingyuan ^d   Cao, Feng ^a,b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c Department of Gastroenterology   (China)

^d INSTITUTE OF CHEMISTRY   (China)

^e XIDIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; CELL CULTURE; CELL DEATH; CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DECOMPOSITION; DISEASES; FLUORESCENCE IMAGING; IRON; IRON OXIDES; MAGNETIC NANOPARTICLES; MAGNETITE; MAMMALS; PHARMACODYNAMICS; POLYETHYLENE GLYCOLS; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY; TUMORS;

CLINICAL APPLICATION; FE3O4 NANOPARTICLES; GASTRIC CANCER CELLS; INTRAPERITONEAL INJECTIONS; MAGNETIC NANOPARTI CLES (MNPS); MULTI-MODALITY IMAGING; TAIL VEIN INJECTIONS; THERAPEUTIC STRATEGY;

RNA;

ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; IRON; MAGNETITE; MAGNETITE NANOPARTICLE; MICRORNA; MIRN16 MICRORNA, HUMAN;

ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; HUMAN; METABOLISM; MOUSE; NEOPLASMS, EXPERIMENTAL; PATHOLOGY; STOMACH NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; FERROSOFERRIC OXIDE; HUMANS; IRON; MAGNETITE NANOPARTICLES; MICE; MICE, INBRED BALB C; MICRORNAS; NEOPLASMS, EXPERIMENTAL; STOMACH NEOPLASMS;

EID: 84908874028     PISSN: 20403364     EISSN: 20403372     Source Type: Journal    
DOI: 10.1039/c4nr03003f     Document Type: Article

References (32)

1. D. Zhang and D. Fan, Future Oncol., 2010, 6, 527-537.
2. R. Wong and D. Cunningham, Ann. Oncol., 2009, 20, 605-608.
3. L. Hong, Z. Yang, J. Ma and D. Fan, Curr. Drug Targets, 2013, 14, 1118-1127.
4. Q. Ma, X. Wang, Z. Li, B. Li, F. Ma, L. Peng, Y. Zhang, A. Xu and B. Jiang, Oncol. Rep., 2013, 29, 1652-1658.
5. M. Hao, L. Zhang, G. An, W. Sui, Z. Yu, D. Zou, Y. Xu, H. Chang and L. Qiu, J. Hematol. Oncol., 2011, 4, 37.
6. L. Xia, D. Zhang, R. Du, Y. Pan, L. Zhao, S. Sun, L. Hong, J. Liu and D. Fan, Int. J. Cancer, 2008, 123, 372-379.
7. T. Behnke, J. E. Mathejczyk, R. Brehm, C. Wurth, F. R. Gomes, C. Dullin, J. Napp, F. Alves and U. Resch-Genger, Biomaterials, 2013, 34, 160-170.
8. S. Cui, D. Yin, Y. Chen, Y. Di, H. Chen, Y. Ma, S. Achilefu and Y. Gu, ACS Nano, 2013, 7, 676-688.
9. C. H. Fan, C. Y. Ting, H. J. Lin, C. H. Wang, H. L. Liu, T. C. Yen and C. K. Yeh, Biomaterials, 2013, 34, 3706-3715.
10. H. Maeda, H. Nakamura and J. Fang, Adv. Drug Delivery Rev., 2013, 65, 71-79.
11. Y. Zhang, L. Peng, R. J. Mumper and L. Huang, Biomaterials, 2013, 34, 8459-8468.
12. R. Shrestha, M. Elsabahy, S. Florez-Malaver, S. Samarajeewa and K. L. Wooley, Biomaterials, 2012, 33, 8557-8568.
13. K. A. Whitehead, J. Matthews, P. H. Chang, F. Niroui, J. R. Dorkin, M. Severgnini and D. G. Anderson, ACS Nano, 2012, 6, 6922-6929.
14. H. C. Huang, S. Barua, G. Sharma, S. K. Dey and K. Rege, J. Controlled Release, 2011, 155, 344-357.
15. G. Yu, J. Li, W. Yu, C. Han, Z. Mao, C. Gao and F. Huang, Adv. Mater., 2013, 25, 6373-6379.
16. J. Chen, M. Shi, P. Liu, A. Ko, W. Zhong, W. Liao and M. M. Xing, Biomaterials, 2014, 35, 1240-1248.
17. R. Qiao, Q. Jia, S. Huwel, R. Xia, T. Liu, F. Gao, H. J. Galla and M. Gao, ACS Nano, 2012, 6, 3304-3310.
18. Q. Jia, J. Zeng, R. Qiao, L. Jing, L. Peng, F. Gu and M. Gao, J. Am. Chem. Soc., 2011, 133, 19512-19523.
19. S. Liu, Y. Han, R. Qiao, J. Zeng, Q. Jia, Y. Wang and M. Gao, J. Phys. Chem. C, 2010, 114, 21270-21276.
20. F. Wang, X. Song, X. Li, J. Xin, S. Wang, W. Yang, J. Wang, K. Wu, X. Chen, J. Liang, J. Tian and F. Cao, PLoS One, 2013, 8, e61792.
21. H. Lage, Cell. Mol. Life Sci., 2008, 65, 3145-3167.
22. S. Husted, R. Sokilde, L. Rask, S. Cirera, P. K. Busk, J. Eriksen and T. Litman, Mol. Pharmacol., 2011, 8, 2055-2062.
23. H. C. Huang, S. Barua, G. Sharma, S. K. Dey and K. Rege, J. Controlled Release, 2011, 155, 344-357.
24. H. Song, R. He, K. Wang, J. Ruan, C. Bao, N. Li, J. Ji and D. Cui, Biomaterials, 2010, 31, 2302-2312.
25. Q. Jia, J. Zeng, R. Qiao, L. Jing, L. Peng, F. Gu and M. Gao, J. Am. Chem. Soc., 2011, 133, 19512-19523.
26. S. M. Moghimi, A. C. Hunter and J. C. Murray, Pharmacol. Rev., 2001, 53, 283-318.
27. S. Laurent and M. Mahmoudi, Int. J. Mol. Epidemiol. Genet., 2011, 2, 367-390.
28. P. Chandrasekharan, D. Maity, C. X. Yong, K. H. Chuang, J. Ding and S. S. Feng, Biomaterials, 2011, 32, 5663-5672.
29. J. Gao, K. Chen, R. Luong, D. M. Bouley, H. Mao, T. Qiao, S. S. Gambhir and Z. Cheng, Nano Lett., 2012, 12, 281-286.
30. F. F. Teng, X. Meng, X. D. Sun and J. M. Yu, Int. J. Nanomed., 2013, 8, 3703-3713.
31. H. Oliveira, E. Perez-Andres, J. Thevenot, O. Sandre, E. Berra and S. Lecommandoux, J. Controlled Release, 2013, 169, 165-170.
32. M. Rahimi, S. Kilaru, G. E. Sleiman, A. Saleh, D. Rudkevich and K. Nguyen, J. Biomed. Nanotechnol., 2008, 4, 482-490.